Sandbox/table: Difference between revisions
< Sandbox
| Line 14: | Line 14: | ||
==table== | ==table== | ||
{| style="border: 2px solid #DCDCDC; font-size: 90%; width: | {| style="border: 2px solid #DCDCDC; font-size: 90%; width: 30%;" | ||
|+ '''Laboratory findings''' | |+ '''Laboratory findings''' | ||
|- | |- | ||
! style="width: | ! style="width: 75px; background: #4479BA; text-align: center;"|{{fontcolor|#FFF|Test}} | ||
! style="width: | ! style="width: 200px; background: #4479BA; text-align: center;"| {{fontcolor|#FFF|Findings}} | ||
|- | |- | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;"| '''[[White blood cells]] count''' | | style="background: #F5F5F5; padding: 5px; text-align: center;"| '''[[White blood cells]] count''' | ||
| Line 27: | Line 27: | ||
|- | |- | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;"| '''[[Liver function tests]]''' | | style="background: #F5F5F5; padding: 5px; text-align: center;"| '''[[Liver function tests]]''' | ||
| style="background: #DCDCDC; padding: 5px;"| Raised [[aspartate aminotransferase]]<br>Raised[[alanine aminotransferase]]<br>Extended [[prothrombin time]]<br>Extended[[partial thromboplastin time]] | | style="background: #DCDCDC; padding: 5px;"| Raised [[aspartate aminotransferase]]<br>Raised[[alanine aminotransferase]]<br>Extended [[prothrombin time]]<br>Extended[[partial thromboplastin time]] | ||
|- | |- | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;"| '''[[Proteins]]''' | | style="background: #F5F5F5; padding: 5px; text-align: center;"| '''[[Proteins]]''' | ||
| style="background: #DCDCDC; padding: 5px;"| [[Hyperproteinemia]] | | style="background: #DCDCDC; padding: 5px;"| [[Hyperproteinemia]] | ||
|- | |- | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;"| '''[[Urinalysis]]''' | | style="background: #F5F5F5; padding: 5px; text-align: center;"| '''[[Urinalysis]]''' | ||
| style="background: #DCDCDC; padding: 5px;"| [[Proteinuria]] | | style="background: #DCDCDC; padding: 5px;"| [[Proteinuria]] | ||
|} | |} | ||
Revision as of 19:06, 20 June 2014
The following table contains the main risk factors for CDI:[1][2][3][2][2]
| Alterations in the coagulation system |
|---|
| Consumption of clotting factors |
| Increased concentrations of fibrin degradation products |
| Disseminated intravascular coagulation |
table
| Test | Findings |
|---|---|
| White blood cells count | Leucopenia (1000 cells/μL) Lymphopenia Neutrophilia |
| Blood smear | Left shift Atypical lymphocytes |
| Liver function tests | Raised aspartate aminotransferase Raisedalanine aminotransferase Extended prothrombin time Extendedpartial thromboplastin time |
| Proteins | Hyperproteinemia |
| Urinalysis | Proteinuria |
table
| Diagnostic test | North America | South America | Middle East | Far East |
|---|---|---|---|---|
ELISA (serology) detects:
|
† There is a reported prevalence of 15% in the Northeast of the US.
- ↑ Hensgens MP, Goorhuis A, Dekkers OM, Kuijper EJ (2012). "Time interval of increased risk for Clostridium difficile infection after exposure to antibiotics". J Antimicrob Chemother. 67 (3): 742–8. doi:10.1093/jac/dkr508. PMID 22146873.
- ↑ 2.0 2.1 2.2 Knight, Christopher L.; Surawicz, Christina M. (2013). "Clostridium difficile Infection". Medical Clinics of North America. 97 (4): 523–536. doi:10.1016/j.mcna.2013.02.003. ISSN 0025-7125.
- ↑ Planche, Tim (2013). "Clostridium difficile". Medicine. 41 (11): 654–657. doi:10.1016/j.mpmed.2013.08.003. ISSN 1357-3039.